MedCram cover image

MedCram

Episode 81. Current COVID Risk Assessment: BA.2.86 Variant, Boosters, and More

Sep 12, 2023
Dr. Roger Seheult examines the COVID risk assessment, including the BA.2.86 Variant, boosters, hospitalizations, and T cell immunity. He also discusses a study on myocarditis in COVID-19 recovered patients and factors to consider for booster shots.
24:30

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • The BA 2.86 variant of SARS-CoV-2 may not be as significant a threat as initially thought, as other variants are responsible for the majority of infections and hospitalizations.
  • Updated booster shots, like the Moderna booster, can significantly increase neutralizing antibody levels against circulating variants, but risks such as myocarditis should be discussed with healthcare providers.

Deep dives

Prevalence of the virus and hospitalizations

The prevalence of COVID-19 is increasing nationwide based on wastewater detection, indicating a steady rise in the disease. Hospitalizations have also increased proportionally in both the United States and Canada, suggesting that the benefits of vaccination and previous infection may be wearing off.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode